Division of Urology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Neurourol Urodyn. 2012 Jan;31(1):60-3. doi: 10.1002/nau.21189. Epub 2011 Aug 8.
The reported incidence of urinary incontinence (UI) after radical prostatectomy (RP) ranges from 2.5 to 87%. We reviewed data from the Center for Prostate Disease Research (CPDR) to determine the incidence of patient reported UI after RP (postRPUI) and establish risk factors for postRPUI.
We obtained IRB approval to query the CPDR database on all patients undergoing RP between 1990 and 2007. We assessed patient age, nerve sparing status, blood loss, margin status, stage, and patient self-reported incontinence status as entered into the database. Patients were counted as having UI only if the database showed patient reported UI in every follow-up encounter. Patients were counted as permanently dry if at any time in the follow-up they answered that they had no UI.
Four thousand three hundred seventy four patients underwent RP without radiation therapy or hormonal ablation between 1990 and 2007. Complete data were available for 1,616 (37%) and 1,459 (90.3%) reported UI more than 1 year after RP with a median follow-up of 50.7 months. Older age is an independent risk factor for UI (OR = 1.021, P ≤ 0.0003). Nerve sparing, blood loss, stage of cancer, and margin status were not predictive for UI.
Our data indicate that patient reported post-RPUI is higher than expected but is not related to the nerve sparing technique, stage of cancer nor blood loss at the time of surgery.
根治性前列腺切除术(RP)后尿失禁(UI)的报告发生率为 2.5%至 87%。我们回顾了前列腺疾病研究中心(CPDR)的数据,以确定 RP 后患者报告的 UI(postRPUI)的发生率,并确定 postRPUI 的风险因素。
我们获得了 IRB 的批准,以查询 1990 年至 2007 年间接受 RP 的所有患者的 CPDR 数据库。我们评估了患者的年龄、神经保留状态、失血量、切缘状态、分期以及患者自我报告的尿失禁状态,这些信息都输入到数据库中。只有当数据库显示患者在每次随访中都报告了 UI 时,才将患者算作有 UI。如果患者在随访中的任何时候回答他们没有 UI,则将患者算作永久性干燥。
1990 年至 2007 年间,4374 例患者接受了无放疗或激素消融的 RP。1616 例(37%)和 1459 例(90.3%)患者的完整数据可用于 RP 后 1 年以上报告 UI,中位随访时间为 50.7 个月。年龄较大是 UI 的独立危险因素(OR=1.021,P≤0.0003)。神经保留、失血量、癌症分期和切缘状态与 UI 无关。
我们的数据表明,患者报告的 post-RPUI 高于预期,但与神经保留技术、癌症分期或手术时的失血量无关。